Key resources

We’re excited to release our new clear, concise and clinically relevant infographic Which option to slow myopia?to help you with what we have learnt is the main practitioner need in myopia management, and the most popular discussion topic in the Myopia Profile Facebook group – guidance in selecting the right treatment for your patient. A world first, evidence based decision …

How can you tell if your myopia management strategy has been a success? Our new infographic Which option to slow myopia? is designed to translate research into practice, and is a world first, evidence based clinical decision making tool designed to fill in a gap in the currently available resources. One of the key gaps in putting myopia management into …

Most eye care practitioners don’t routinely measure axial length in clinical practice, mainly due to lack of access to the instrumentation and its expense. This is not the only reason, though, that axial length (AXL) measurement is a bit of a problematic measure for gauging myopia management success in a clinical setting. When I was leading the authorship of the …

There is no doubt that the best first choice for myopia control is a contact lens option, which both corrects ametropia and shows reliable myopia control efficacy. One of the key barriers to pediatric contact lens wear is concern about safety, however, for both practitioners and parents. Mark Bullimore1 recently published a meta-analysis of pediatric soft contact lens studies (SCL) …

There is no one-size-fits-all with myopia management, so which option should you choose for your individual patient? Here we are going to get started with some clinical decision trees, then later we will get into the detail of each of our three main myopia control treatments – atropine, OrthoK (OK) and multifocal soft contact lenses (MFSCLs: a blanket term for …

Let’s cut to the chase – until further notice, you can consider low dose (0.01%) atropine, soft multifocal CL’s and OrthoK as all quite similar in terms of their myopia control efficacy, being around 50% on average. A network meta-analysis of sixteen different interventions studied for myopia control showed these options to all have similar efficacy when their refractive and …

We have a convincing evidence base for several optical, one pharmacological and visual environment solutions to reduce the progression of childhood myopia, but nothing guarantees 100% efficacy. Because of this, even in when under a successful myopia management strategy, a child’s myopia may still progress. It is important to manage parental and patient expectations about myopia management – that we …

This one hour lecture, delivered to final year QUT optometry students in August 2017, covers the ‘why’ of myopia control; understanding the relative risks of doing something versus doing nothing; a brief literature review of mechanisms and options; putting it into practice and clinical resources available online. Since, then, my message on efficacy has been updated and simplified, but the …

In this short video, I introduce Myopia Profile, explain how I use it in practice, and describe two typical childhood myopia cases. I routinely use the profile when I am examining a child who is already myopia or is showing risk of developing myopia. By stepping through the different stages I am able to explain to the child, and their …

Speaking at conferences in Australia, New Zealand, Europe and America on myopia control has seen numerous practitioners clearly interested in my approach to myopia management. The difficulty in the busy clinician translating research into practice is that full spectrum myopia management demands knowledge of epidemiology, optics, specialty contact lenses and binocular vision. That’s a lot to get your head around, …